Source recordFED

Pharma In Silica inc.

Federal grants & contributions· Industrial Research Assistance Program – Contributions to Firms· National Research Council Canada· FY2022· $179,500· BN 743257313· QC

Description

Development of a silica-based therapeutic vector to increase the efficacy and reduce the toxicity of certain drugs used to treat cancer.

Amendment chain · 3 entries

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $179,500 at start, $179,500 after amendment #2 (+$0).

$179,500$0Original · 2021-11-01 (start date) · total $179,500Amendment 1 · 2022-01-05 · total $179,500Amendment 2 · 2022-10-05 · total $179,500
  • #02021-11-01$179,500
  • #12022-01-05$179,500
  • #22022-10-05$179,500
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2021-11-01(start date)$179,500—Development of a silica-based therapeutic vector to increase the efficacy and reduce the toxicity of certain d…
#1 amendment2022-01-05$179,500+$0Development of a silica-based therapeutic vector to increase the efficacy and reduce the toxicity of certain d…
#2 amendment2022-10-05$179,500+$0Development of a silica-based therapeutic vector to increase the efficacy and reduce the toxicity of certain d…

Related records · 11

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other current agreements for the same recipient (business number 743257313)

RefDepartment · programCurrent valueFY
172-2023-2024-Q3-1012956National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms$75,000FY2024
172-2020-2021-Q4-963215National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms$34,690FY2021
172-2020-2021-Q4-967519National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Innovation Assistance Program$16,257FY2021
172-2020-2021-Q3-960303National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Innovation Assistance Program$43,278FY2021
172-2020-2021-Q1-949230National Research Council Canada | Conseil national de recherches Canada · Innovation Assistance Program$30,492FY2021
172-2019-2020-Q3-936021National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms$99,900FY2020

Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)

RefRecipientFiscal yearCurrent valueFY
172-2025-2026-Q2-1034675Mediphage Bioceuticals, Inc.FY2027$63,380FY2027
172-2025-2026-Q3-1037522OBKIO INC.FY2026$50,000FY2026
172-2025-2026-Q3-1037889SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INCFY2026$25,000FY2026
172-2025-2026-Q2-1034040Griffith Foods LimitedFY2026$54,880FY2026
172-2025-2026-Q3-1037273Apollo Machine & Welding Ltd.FY2026$230,000FY2026

Cite as: Glassbox record view · Federal grants & contributions · 172-2021-2022-Q3-980232 · retrieved 2026-11-13.